What is the full form of ATR in stock market?
In technical analysis and equity trading, ATR stands for Average True Range. Developed by J. Welles Wilder Jr., it is a technical indicator used by market participants to measure asset price volatility by factoring in price gaps and limit moves over a specified retrospective time period, typically set across fourteen trading sessions.
Related FAQs
AptarGroup operates as a global manufacturer of consumer product dispensing, sealing, and active packaging solutions, exposing investors to specific industrial risks.
There is no scientific evidence that Ayurveda can "cure" arthritis, which is a chronic condition that can involve over 100 different types of joint disorders.
Aptiv PLC maintains a specialized global workforce of more than 51,000 employees.
Pharmaceuticals represent a classic defensive sector characterized by resilient cash flows, inelastic consumer demand, and robust margins that tend to outperform during broader economic downturns.
Alpha Pro Tech Ltd. maintains modest future prospects shaped by its positioning within disposable protective garments and building supply segments.
AptarGroup, Inc. operates within the containers, packaging, and drug delivery device manufacturing industry.
A residential home constructed in the year 2000 is generally not considered old in the broader context of real estate architecture and structural engineering.
AptarGroup, Inc. registers annual revenues scaling comfortably into the range of USD 3.4 billion to USD 3.5 billion, reflecting its prominent market position in global dispensing, sealing, and active packaging solutions.
The Average True Range (ATR) technical indicator can be applied across various chart timeframes depending on your specific trading style and strategy.
Selecting the ultimate pharmaceutical equity for long-term investment involves prioritizing companies with diverse drug portfolios, strong patent protections, and consistent research and development productivity. Global leaders such as Merck & Co.
Investing in pharmaceutical stocks can be highly rewarding for investors looking to capture long-term secular growth trends, technological breakthroughs in genomics and oncology, and reliable dividend income.
Equity research analysts covering AptarGroup (ticker ATR) generally maintain a consensus rating leaning toward a moderate buy or hold, balancing its defensive packaging profile against cyclical industrial demand.